Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Bemærk venligst, at rapporten udelukkende findes på engelsk ALK reports revenue up 13% with sales growth across its portfolio, outlook updated (unaudited) ALK’s revenue growth increased during Q2 on...
-
ALK reports revenue up 13% with sales growth across its portfolio, outlook updated (unaudited) ALK’s revenue growth increased during Q2 on continued strong momentum for tablet sales and a recovery in...
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddeler i dag, at selskabet opjusterer forventningerne til regnskabsåret 2021, især til stigende indtjening, for at afspejle et bedre salgsforecast samt...
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the company is upgrading its full-year financial outlook especially with regards to increasing earnings to reflect an improved sales...
-
Bestyrelsen for ALK-Abelló A/S (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddeler i dag, at den vil indstille Alan Main, tidligere direktør for Consumer Healthcare i Sanofi, som uafhængigt medlem af...
-
The Board of Directors of ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) is to nominate the former head of Consumer Healthcare at Sanofi, Alan Main, as an independent member of the Board of ALK-Abelló...
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) offentliggør delårsrapport for første halvår (Q2) 2021 onsdag den 11. august 2021. ALK afholder samme dag kl. 13.30 (CEST) en telefonkonference for...
-
On Wednesday, 11 August 2021, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its six-month interim report (Q2) 2021. ALK will host a meeting for analysts and institutional investors that day at...
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) vil lancere Jext® i Kina via et partnerskab med den førende leverandør af adrenalin, Grandpharma.Jext® forventes at blive den første adrenalinpen på det...
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) to launch its adrenaline autoinjector (AAI), Jext®, in China via a partnership with leading supplier of adrenaline, Grandpharma.Jext® is expected to be the...